Pennsylvania HB1827 mandates medical assistance and insurance coverage for osteoporosis screening, prevention, and treatment for menopausal.
HB1827 requires medical assistance and insurance coverage for osteoporosis screening, prevention, and treatment for individuals who have reached menopause. Coverage includes bone mineral density testing, hormonal and nonhormonal treatments, and FDA-approved drugs, devices, and combination products. The Department of Human Services must seek a state plan amendment or federal waiver if needed. Insurers must cover preventative measures, testing, and treatments for osteoporosis. The act aims to provide early coverage to prevent advanced osteoporosis and related fractures.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.